ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.
Also called NCT04742205
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 154 participants
- Sponsor
- Kathmandu Medical College and Teaching Hospital
- Registry
-
NCT04742205
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Nepal
- Registry status
- Completed
Technical summary
Registry record NCT04742205. Randomized; triple masking; primary purpose treatment. Start 2021-02-08 (actual); primary completion 2023-12-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
- Condition
- Cerebral Hemorrhage
- Intervention (Drug)
- Tranexamic Acid 500 MG
- Lead sponsor
- Kathmandu Medical College and Teaching Hospital
Record details
- Record id
cardio:ct-nct04742205- Content hash
0e450f037f60288aa8fa62e3e7fc8057659242b52511ceab60448b1467e060a4